Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 30;3(4):100442.
doi: 10.1016/j.inpm.2024.100442. eCollection 2024 Dec.

The effectiveness of sacral lateral branch radiofrequency neurotomy for posterior sacroiliac joint complex pain in patients selected by dual sacral lateral branch blocks; A real-world cohort study

Affiliations

The effectiveness of sacral lateral branch radiofrequency neurotomy for posterior sacroiliac joint complex pain in patients selected by dual sacral lateral branch blocks; A real-world cohort study

Austin Boos et al. Interv Pain Med. .

Abstract

Background: Previous study of spinal neurotomy procedures indicates that stringent block selection improves outcomes. However, this pattern is not established for sacral lateral branch radiofrequency neurotomy (SLBRFN). Few SLBRFN studies have used stringent block selection criteria such as ≥80 % pain reduction following dual sacral lateral branch blocks (SLBB).

Objective: Evaluate the effectiveness of SLBRFN in patients with ≥80 % pain relief following dual SLBBs.

Methods: Retrospective single-arm cohort study of consecutive patients from two Canadian musculoskeletal and pain clinics who underwent first-time SLBRFN after report of ≥80 % pain relief following dual diagnostic SLBBs. Patients were identified by electronic medical record query between 2016 and 2022. The primary outcome was the proportion of individuals with a ≥50 % reduction in the numeric pain rating scale (NPRS) score three months after SLBRFN. Secondary outcomes included the proportion of responders achieving the minimal clinically important difference (MCID) on the pain disability quality-of-life questionnaire (PDQQ), and the duration and mean percentage of pain relief among those with recurrent symptoms after a successful SLBRFN.

Results: Of the 70 participants included, 32 (45.7 %; 95 % CI = 34.6-57.3) reported a ≥50 % reduction in NPRS, and 35 (50.0 %; 95 % CI = 38.6-61.4) achieved the MCID on the PDQQ at 3-months. Among the 17 patients who reported a return of symptoms, the mean duration of relief was 8.0 ± 3.5 months, and the mean percentage of pain relief was 77.9 % ± 16.4 %. Logistic regression models revealed that the use of multi-tined RF probes and lower patient BMI were associated with treatment success.

Discussion/conclusion: SLBRFN reduced pain and disability in approximately 50 % of patients at 3 months when selected using relatively restrictive selection criteria. Treatment success was associated with multi-tined RF probe type and lower patient BMI. Larger prospective studies assessing long-term outcomes are needed to further evaluate the impact of different selection criteria and techniques on SLBRFN effectiveness.

Keywords: Dual lateral branch block; Radiofrequency ablation; Sacroiliac joint pain.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Zachary McCormick, MD reports a relationship with Polytechnic Institute of Santarém that includes: board membership. Zachary McCormick, MD reports a relationship with Avanos Medical Inc that includes: consulting or advisory and funding grants. Zachary McCormick, MD reports a relationship with Boston Scientific Corporation that includes: funding grants. Zachary McCormick, MD reports a relationship with Relievant Medsystems Inc that includes: funding grants. Zachary McCormick, MD reports a relationship with Saol International Ltd that includes: consulting or advisory and funding grants. Zachary McCormick, MD reports a relationship with spine biopharma that includes: funding grants. Zachary McCormick, MD reports a relationship with SPR Therapeutics Inc that includes: funding grants. Zachary McCormick, MD reports a relationship with Stratus Medical that includes: funding grants. Zachary McCormick, MD reports a relationship with Stryker Spine that includes: consulting or advisory. Zachary McCormick, MD reports a relationship with OrthoSon that includes: consulting or advisory. Taylor Burnham, DO reports a relationship with Diros Technology Inc that includes: funding grants. Taylor Burnham, DO reports a relationship with Avanos Medical Inc that includes: consulting or advisory. Aaron Conger, DO reports a relationship with Stratus LLC that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

References

    1. Roberts S.L. Sacroiliac joint anatomy. Phys Med Rehabil Clin. 2021;32(4):703–724. doi: 10.1016/j.pmr.2021.05.007. - DOI - PubMed
    1. Roberts S.L., Burnham R.S., Ravichandiran K., Agur A.M., Loh E.Y. Cadaveric study of sacroiliac joint innervation: implications for diagnostic blocks and radiofrequency ablation. Reg Anesth Pain Med. 2014;39(6):456–464. doi: 10.1097/AAP.0000000000000156. - DOI - PubMed
    1. Cox R.C., Fortin J.D. The anatomy of the lateral branches of the sacral dorsal rami: implications for radiofrequency ablation. Pain Physician. 2014;17(5):459–464. - PubMed
    1. Kennedy D.J., Engel A., Kreiner D.S., Nampiaparampil D., Duszynski B., MacVicar J. Fluoroscopically guided diagnostic and therapeutic intra-articular sacroiliac joint injections: a systematic review. Pain Med. 2015;16(8):1500–1518. doi: 10.1111/pme.12833. - DOI - PubMed
    1. Eissa M., Moustafa A., Sawan M., Nazim W., Salah A. Comparison of efficacy of lateral branch radiofrequency denervation and intraarticular depot methylprednisolone injection for sacroiliac joint pain. Pan Arab J Neurosurg. 2022;17(2):43–49. doi: 10.21608/pajn.2022.112431.1043. - DOI

LinkOut - more resources